The role of Wnt, ARL4C, and Sema3A in developmental process and disease pathogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Oral tumors, including squamous cell carcinoma, ameloblastoma, and adenoid cystic carcinoma, lack identified major driver events and molecular targets for therapy.
• Aberrant signal transduction pathways are implicated in oral tumor formation, necessitating further investigation into their roles.
• The Wnt/β-catenin-dependent pathway is crucial for development, homeostasis, and pathogenesis, regulating cellular functions via transcriptional activity.

Purpose of the Study:

• To elucidate the function of aberrantly activated signal transduction pathways in oral tumorigenesis.
• To investigate the roles of ADP-ribosylation factor (ARF)-like 4c (ARL4C) and Semaphorin 3A (Sema3A) in oral tumor development.
• To highlight recent advances in understanding the Wnt/β-catenin pathway, ARL4C, and Sema3A in oral tumors.

Main Methods:

• Pathological studies of oral tumors.
• Experimental characterization of gene and protein functions.
• Review of recent scientific literature on Wnt/β-catenin signaling, ARL4C, and Sema3A.

Main Results:

• The Wnt/β-catenin-dependent pathway regulates the expression of ARL4C and Sema3A.
• ARL4C and Sema3A play significant roles in developmental processes and tumor formation.
• Aberrant activation of this pathway contributes to the pathogenesis of common oral tumors.

Conclusions:

• The Wnt/β-catenin pathway, ARL4C, and Sema3A are critical in oral tumor development and present potential therapeutic targets.
• Understanding these molecular mechanisms is essential for advancing anti-tumor therapies for oral cancers.
• Further research into these pathways may lead to novel diagnostic and therapeutic strategies for oral malignancies.